Royal Bank of Canada

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
24,810
Total Value
350517986000
Accession Number
0001140361-25-019231
Form Type
13F-HR
CIK
0001000275
Manager Name
Royal Bank of Canada
Data Enrichment
78% identified
19,259 identified5,551 unidentified

Holdings

24,810 positions
Manager:
SEC
Search and click to pin securities to the top
Page 310 of 331
Contineum Therapeutics, Inc.
CTNM|21217B100
Shares:
264(-98.6%)
Value:
$2.0M(-99.3%)
886364173
886364173
Shares:
24(-89.6%)
Value:
$2.0M(-92.0%)
Vistagen Therapeutics, Inc.
VTGN|92840H400
Shares:
911(-51.0%)
Value:
$2.0M(-60.0%)
FARMER BROTHERS CO
FARM|307675108
Shares:
834(-71.2%)
Value:
$2.0M(-60.0%)
Cipher Mining Inc.
CIFR|17253J106
Shares:
832(-93.0%)
Value:
$2.0M(-96.4%)
Kenon Holdings Ltd.
KEN|Y46717107
Shares:
58(+7.4%)
Value:
$2.0M(+0.0%)
75526L878
75526L878
Shares:
56
Value:
$2.0M
Sight Sciences, Inc.
SGHT|82657M105
Shares:
1046(-39.5%)
Value:
$2.0M(-71.4%)
78468R515
78468R515
Shares:
102(-55.6%)
Value:
$2.0M(-60.0%)
251936100
251936100
Shares:
8333(+1143.7%)
Value:
$2.0M(+100.0%)
Neonode Inc.
NEON|64051M709
Shares:
190(+0.0%)
Value:
$2.0M(+0.0%)
78468R440
78468R440
Shares:
71(-31.7%)
Value:
$2.0M(-33.3%)
Acrivon Therapeutics, Inc.
ACRV|004890109
Shares:
849(-48.2%)
Value:
$2.0M(-80.0%)
02376RAF9
02376RAF9
Shares:
0
Value:
$2.0M(+0.0%)
38149W531
38149W531
Shares:
100
Value:
$2.0M
Actinium Pharmaceuticals, Inc.
ATNM|00507W206
Shares:
1280(-79.0%)
Value:
$2.0M(-75.0%)
EMX Royalty Corp
EMX|26873J107
Shares:
744(-48.9%)
Value:
$2.0M(-33.3%)
690145206
690145206
Shares:
185
Value:
$2.0M
Ispire Technology Inc.
ISPR|46501C100
Shares:
868(-20.4%)
Value:
$2.0M(-66.7%)
74347R214
74347R214
Shares:
40
Value:
$2.0M